Polynovo Ltd (ASX:PNV) insider David Williams acquired 79,188 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were acquired at an average cost of A$0.74 ($0.52) per share, with a total value of A$58,203.18 ($41,278.85).
ASX:PNV remained flat at $A$0.71 ($0.50) during trading hours on Friday. The company had a trading volume of 2,902,538 shares. Polynovo Ltd has a 12 month low of A$0.46 ($0.32) and a 12 month high of A$0.80 ($0.56).
COPYRIGHT VIOLATION NOTICE: “Polynovo Ltd (PNV) Insider David Williams Buys 79,188 Shares” was first reported by Stock Observer and is the sole property of of Stock Observer. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.thestockobserver.com/2019/03/15/polynovo-ltd-pnv-insider-david-williams-buys-79188-shares.html.
Polynovo Company Profile
Polynovo Limited, a medical device company, designs, develops, and manufactures dermal regeneration solutions in Australia. The company focuses on the development and commercialization of medical devices using its NovoSorb technology in the treatment of burns, surgical wounds, and negative pressure wound therapy.
Read More: No Load Funds
Receive News & Ratings for Polynovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polynovo and related companies with MarketBeat.com's FREE daily email newsletter.